Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;19(3):749-760.
doi: 10.1002/alz.12700. Epub 2022 Jun 6.

A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study

Affiliations

A combination model of AD biomarkers revealed by machine learning precisely predicts Alzheimer's dementia: China Aging and Neurodegenerative Initiative (CANDI) study

Feng Gao et al. Alzheimers Dement. 2023 Mar.

Abstract

Introduction: To test the utility of the "A/T/N" system in the Chinese population, we study core Alzheimer's disease (AD) biomarkers in a newly established Chinese cohort.

Methods: A total of 411 participants were selected, including 96 cognitively normal individuals, 94 patients with mild cognitive impairment (MCI) patients, 173 patients with AD, and 48 patients with non-AD dementia. Fluid biomarkers were measured with single molecule array. Amyloid beta (Aβ) deposition was determined by 18F-Flobetapir positron emission tomography (PET), and brain atrophy was quantified using magnetic resonance imaging (MRI).

Results: Aβ42/Aβ40 was decreased, whereas levels of phosphorylated tau (p-tau) were increased in cerebrospinal fluid (CSF) and plasma from patients with AD. CSF Aβ42/Aβ40, CSF p-tau, and plasma p-tau showed a high concordance in discriminating between AD and non-AD dementia or elderly controls. A combination of plasma p-tau, apolipoprotein E (APOE) genotype, and MRI measures accurately predicted amyloid PET status.

Discussion: These results revealed a universal applicability of the "A/T/N" framework in a Chinese population and established an optimal diagnostic model consisting of cost-effective and non-invasive approaches for diagnosing AD.

Keywords: Alzheimer's disease; MRI; amyloid PET; fluid biomarker.

PubMed Disclaimer

References

REFERENCES

    1. Zetterberg H, Bendlin BB. Biomarkers for Alzheimer's disease‐preparing for a new era of disease‐modifying therapies. Mol Psychiatry. 2021;26(1):296‐308. https://doi.org/10.1038/s41380‐020‐0721‐9
    1. Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross‐sectional study. Lancet Public Health. 2020;5(12):e661‐e671. https://doi.org/10.1016/S2468‐2667(20)30185‐7
    1. Jack CR, Jr., Bennett DA, Blennow K, et al. NIA‐AA research framework: toward a biological definition of Alzheimer's disease. Alzheimer's Dementia. 2018;14(4):535‐562. https://doi.org/10.1016/j.jalz.2018.02.018
    1. Wu X, Xiao Z, Yi J, et al. Development of a plasma biomarker diagnostic model incorporating ultrasensitive digital immunoassay as a screening strategy for Alzheimer Disease in a Chinese population. Clin Chem. 2021;67(12):1628‐1639. https://doi.org/10.1093/clinchem/hvab192
    1. Mao C, Sha L, Li J, et al. Relationship between general cognition, visual assessed cortical atrophy, and cerebrospinal fluid biomarkers in Alzheimer's disease: a cross‐sectional study from a Chinese PUMCH cohort. J Alzheimers Dis. 2021;82(1):205‐214. https://doi.org/10.3233/JAD‐210344

Publication types

MeSH terms

LinkOut - more resources